Journal
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
Volume 28, Issue 9, Pages 819-826Publisher
WILEY
DOI: 10.1002/hed.20410
Keywords
CYP1A1; CYP2E1; GSTM1; GSTT1; genetic polymorphism; head and neck cancer
Categories
Ask authors/readers for more resources
Background. Alcohol intake and tobacco smoke, in addition to other environmental and genetic factors, have been associated with head and neck cancer. We evaluated the role of metabolic enzyme polymorphisms on the risk of head and neck cancer in a hospital-based case-control study. Methods. CYP1A1Mspl, CYP2E1Pstl, GSTM1, and GSTT1polymorphisms were evaluated in 103 histologically confirmed head and neck cancer cases and 102 controls by means of polymerase chain reaction-restriction fragment length polymorphism methods. Results. GSTM1 null increased the risk of head and neck cancer (odds ratio [OR], 2.2; 95% confidence interval [95% Cl], 1.243.79), oral cancer (OR, 2.8; 95% Cl, 1.28-5.98), and pharyngeal cancer (OR, 2.2; 95% Cl, 1.08-4.63). CYP2E1Pst1 polymorphism indicated a risk for oral cancer (OR, 3.6; 95% Cl, 1.29-11.56). The effect of GSTM1 null and CYP1A1 polymorphism increased the risk of head and neck cancer (OR, 2A; 95% Cl, 1.13-5.10). Conclusions. GSTM1 null alone or associated with CYP1A1 increased the risk of head and neck cancer; the CYP2E1Psd mutated allele increased the risk for only oral cancer. (c) 2006 Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available